57 results
424B4
LGVN
Longeveron Inc - Ordinary Shares
17 Apr 24
Prospectus supplement with pricing info
5:07pm
payments under any additional collaboration agreements we obtain;
the extent to which we are obligated to reimburse, or are entitled to reimbursement
8-K
EX-10.1
LGVN
Longeveron Inc - Ordinary Shares
11 Apr 24
Longeveron Announces Pricing of $5.25 Million Public Offering
5:10pm
of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf
424B4
LGVN
Longeveron Inc - Ordinary Shares
10 Apr 24
Prospectus supplement with pricing info
7:48am
a management fee equal to 1.0% of the aggregate gross proceeds raised in this offering, reimbursement for non-accountable expenses in an amount up … to reimbursement of, clinical trial costs under future collaboration agreements, if any;
the costs of preparing, filing and prosecuting patent applications
8-K
EX-10.1
odommaaoe
22 Dec 23
UPDATE -- Longeveron Announces $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:44am
8-K
EX-10.1
smbbvwp
13 Oct 23
Longeveron Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:00am
8-K
EX-1.1
l4hzh0z 75
18 Aug 23
Entry into a Material Definitive Agreement
4:34pm